BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/12/2023 9:13:35 AM | Browse: 214 | Download: 610
 |
Received |
|
2022-12-26 09:07 |
|
Peer-Review Started |
|
2022-12-26 09:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-03-13 05:44 |
|
Revised |
|
2023-03-15 14:24 |
|
Second Decision |
|
2023-04-14 03:18 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-04-14 09:51 |
|
Articles in Press |
|
2023-04-14 09:51 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-05-05 00:51 |
|
Publish the Manuscript Online |
|
2023-05-12 09:13 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Immuno-oncology-microbiome axis of gastrointestinal malignancy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Quan Lin, Shi-Wei Guan and Hai-Bo Yu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hai-Bo Yu, MD, Chief Doctor, Department of Surgery, Wenzhou Central Hospital, The Dingli Clinical Institute of Wenzhou Medical University, No. 252 Baili East Road, Wenzhou 325000, Zhejiang Province, China. yuhaibozjwz@163.com |
| Key Words |
Gut microbiome; Intratumor microbiome; Gastrointestinal malignancy; Tumor microenvironment; Immunity; Therapy |
| Core Tip |
The gut and intratumor microbiome can influence tumor progression by modulating host metabolism and the immune and immune tone of the tumor microenvironment, which is defined as the immuno-oncology-microbiome (IOM) axis. The proposed the IOM axis provides a new target for tumor microbiome and tumor immunity. Current studies have shown that immunotherapy with fecal microbiota transplantation or microbial metabolism have certain effects. This review aims to explore the mechanism of the IOM axis of gastrointestinal malignancies, to reveal the mechanism and progress of gut and intratumor microbiome in gastrointestinal malignancies. Providing new insights into the research related to gastrointestinal malignancies. |
| Publish Date |
2023-05-12 09:13 |
| Citation |
Lin Q, Guan SW, Yu HB. Immuno-oncology-microbiome axis of gastrointestinal malignancy. World J Gastrointest Oncol 2023; 15(5): 757-775 |
| URL |
https://www.wjgnet.com/1948-5204/full/v15/i5/757.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v15.i5.757 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
